Loading organizations...
Loading organizations...

1849 bio: Biotech company engineering microbes for biomining, enabling efficient metal extraction from low-quality ores for the mining industry.
1849 bio has raised $500K across 1 funding round.
Key people at 1849 bio.
1849 bio was founded in 2024 by Jai Padmakumar (Founder) and Yongjin Park (Founder).
1849 bio has raised $500K in total across 1 funding round.
Based in San Francisco, California, 1849 bio is an early-stage biotechnology company that engineers specialized microbes to extract metals from low-quality and difficult-to-process ores. The company's biomining technology targets the recovery of copper, gold, and nickel from unprofitable resources such as chalcopyrite. By utilizing these engineered microbes, the firm aims to reduce extraction costs to approximately $1 per ton of ore and unlock access to an estimated 100 million tonnes of stranded copper globally. Operating with a team of three employees, the startup is backed by lead investor Y Combinator and participated in the accelerator's Summer 2024 batch. To date, the enterprise has raised $125,000 in early-stage funding to develop and license its biological extraction solutions to commercial mining operators. 1849 bio was founded in 2024 by Jai Padmakumar and Yongjin Park.
1849 bio was founded in 2024 by Jai Padmakumar (Founder) and Yongjin Park (Founder).
1849 bio has raised $500K in total across 1 funding round.
1849 bio's investors include Alumni Ventures, Pioneer Fund, Y Combinator.
Key people at 1849 bio.
1849 Bio is a cutting-edge biotech startup engineering microbes to enable ultra-cheap, sustainable extraction of metals like copper and gold from low-grade and difficult-to-process ores. Their genetically engineered microbes unlock billions of dollars’ worth of trapped metals, such as chalcopyrite copper, which conventional mining methods cannot economically extract. By enhancing microbial efficiency and integrating with existing mining infrastructure, 1849 Bio offers miners a cost-effective, faster, and environmentally friendly alternative to traditional metal extraction, addressing both financial and ecological challenges in the mining industry[1][2][3][4].
For an investment firm, 1849 Bio’s mission centers on revolutionizing metal extraction through biotechnology, focusing on sectors like mining, clean energy materials, and sustainable industrial processes. Their investment philosophy likely emphasizes breakthrough biotech innovations that unlock value in traditional industries while reducing environmental impact. The company’s impact on the startup ecosystem includes advancing synthetic biology applications in heavy industry and catalyzing sustainable mining practices.
As a portfolio company, 1849 Bio builds engineered microbial platforms that serve mining companies seeking to extract metals more efficiently and sustainably. They solve the problem of uneconomical extraction from low-grade ores, unlocking vast metal reserves and reducing mining’s carbon footprint. Their growth momentum is supported by backing from Y Combinator and industry advisors, positioning them to disrupt a $40 billion metal extraction market[2][3][4].
---
Founded in 2024 by Yongjin Park and Jai Padmakumar, both genetic engineers who met during their PhDs at MIT, 1849 Bio emerged from their shared expertise in bioengineering and a desire to apply synthetic biology to mining challenges. They recognized that while biomining has been used for decades, the microbes themselves had not been optimized for efficiency or broader ore types. This insight led them to engineer microbes capable of bioleaching metals from ores like chalcopyrite, which constitute a large portion of copper deposits but are traditionally unprofitable to mine[3][1].
Early traction included acceptance into Y Combinator and assembling a team of industry-leading advisors, validating the potential of their microbial platform to unlock 100 million tonnes of trapped copper and other metals. Their approach addresses a critical supply gap in copper, essential for electrification and clean energy technologies, while offering a cleaner alternative to conventional mining[2][4].
---
---
1849 Bio rides the convergence of synthetic biology and sustainable industrial innovation, addressing urgent market forces such as the global copper supply gap (projected 20% shortage by 2031) and increasing demand for critical minerals in clean energy technologies like electric vehicles and wind turbines. The timing is crucial as mining faces pressure to reduce its environmental impact while meeting rising metal demand.
Their work exemplifies the trend of applying biotech solutions to traditional heavy industries, potentially transforming mining from a high-pollution sector into a more circular, efficient, and eco-friendly industry. By unlocking previously inaccessible metal reserves, 1849 Bio influences the broader ecosystem by enabling cleaner supply chains and supporting the green energy transition[4][5].
---
Looking ahead, 1849 Bio is poised to scale its microbial platform across multiple metals and mining sites, potentially expanding beyond copper and gold to other critical minerals like lithium and cobalt. Trends shaping their journey include increasing regulatory and investor focus on sustainable mining, advances in synthetic biology tools, and the accelerating global demand for electrification metals.
Their influence may evolve from a niche biotech startup to a foundational technology provider in mining, driving systemic change in how metals are sourced worldwide. This could unlock vast new resource pools, reduce mining’s environmental footprint, and accelerate the clean energy transition, fulfilling their mission to make metal extraction cheaper, cleaner, and more efficient[1][2][4][5].
In essence, 1849 Bio is engineering the microbes that will unlock billions in trapped metals, reshaping mining’s future at the intersection of biology and sustainability.
1849 bio has raised $500K across 1 funding round. Most recently, it raised $500K Seed in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2024 | $500K Seed | Alumni Ventures, Pioneer Fund, Y Combinator |